Biofrontera (BFRI) Cash from Operations (2020 - 2025)

Biofrontera's Cash from Operations history runs 6 years deep, the most recent figure standing at 2415000.0 for Q4 2025.

• In Q4 2025, Cash from Operations fell 137.46% year-over-year to 2415000.0; the TTM figure through Dec 2025 stood at 13400000.0 (down 30.48% YoY), while the FY2025 annual figure was 13400000.0, down 30.48% from the prior year.
• Cash from Operations was 2415000.0 for Q4 2025 at Biofrontera, up from 3785000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 125000.0 in Q2 2022 to a low of 20990000.0 in Q4 2021.
• Historically, Cash from Operations has averaged 4574250.0 across 5 years, with a median of 3384000.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations jumped 111.83% in 2022, then sank 8360.0% in 2023.
• A 5-year view of Cash from Operations shows it stood at 20990000.0 in 2021, then soared by 60.59% to 8272000.0 in 2022, then declined by 7.24% to 8871000.0 in 2023, then jumped by 88.54% to 1017000.0 in 2024, then tumbled by 137.46% to 2415000.0 in 2025.
• The last three Cash from Operations figures came in at 2415000.0 (Q4 2025), 3785000.0 (Q3 2025), and 3100000.0 (Q2 2025), per Business Quant data.